Werewolf Therapeutics Inc (HOWL)

Jun 14, 2025

Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know - MSN

Jun 14, 2025

Jun 13, 2025

Werewolf Therapeutics Adopts New Bylaws and Elects Directors - TipRanks

Jun 13, 2025

Jun 13, 2025

Two Sigma Investments LP Sells 87,168 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 13, 2025

Jun 12, 2025

Werewolf Therapeutics to Participate in the BIO International Convention - GlobeNewswire

Jun 12, 2025

Jun 09, 2025

Jane Street Group LLC Acquires 39,564 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 09, 2025

Jun 08, 2025

Two Sigma Advisers LP Sells 117,200 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 08, 2025

Jun 06, 2025

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Shares Sold by Millennium Management LLC - Defense World

Jun 06, 2025

Jun 03, 2025

Deutsche Bank AG Buys 83,172 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 03, 2025

Jun 01, 2025

Northern Trust Corp Acquires 16,640 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 01, 2025

Jun 01, 2025

Bank of America Corp DE Lowers Stock Position in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 01, 2025

May 31, 2025

Werewolf Therapeutics Announces Q1 2025 Financial Results - MSN

May 31, 2025

May 29, 2025

Werewolf Therapeutics Leaders to Reveal Latest Cancer Treatment Progress at Major Healthcare Conference - Stock Titan

May 29, 2025

May 29, 2025

Werewolf Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference on June 5, 2025 - Nasdaq

May 29, 2025

May 29, 2025

Werewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare Conference - GlobeNewswire

May 29, 2025

May 29, 2025

D. E. Shaw & Co. Inc. Makes New Investment in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

May 29, 2025

May 27, 2025

Werewolf Therapeutics (HOWL) Price Target Lowered by BofA, Buy Rating Maintained | HOWL Stock News - GuruFocus

May 27, 2025

May 27, 2025

Werewolf Therapeutics (HOWL) Price Target Lowered by BofA, Buy R - GuruFocus

May 27, 2025

May 24, 2025

Werewolf Therapeutics (HOWL) Stock Price, News & Analysis - MarketBeat

May 24, 2025

May 22, 2025

Werewolf Therapeutics’ SWOT analysis: innovative platform drives stock potential By Investing.com - Investing.com Nigeria

May 22, 2025

May 22, 2025

Werewolf Therapeutics’ SWOT analysis: innovative platform drives stock potential - Investing.com Australia

May 22, 2025

May 20, 2025

HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124 - GlobeNewswire

May 20, 2025

May 20, 2025

Breakthrough Skin Cancer Treatment: Patient Cancer-Free After 1 Year in Revolutionary IL-2 Drug Trial - Stock Titan

May 20, 2025

May 18, 2025

Dimensional Fund Advisors LP Cuts Position in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

May 18, 2025

May 15, 2025

Werewolf Therapeutics Receives Nasdaq Deficiency Notice - TipRanks

May 15, 2025

May 13, 2025

Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit - GlobeNewswire

May 13, 2025

May 12, 2025

Wedbush Cuts Werewolf Therapeutics (NASDAQ:HOWL) Price Target to $6.00 - Defense World

May 12, 2025

May 10, 2025

Werewolf Therapeutics First Quarter 2025 Earnings: US$0.40 loss per share (vs US$0.39 loss in 1Q 2024) - Yahoo Finance

May 10, 2025

May 10, 2025

Wedbush Adjusts Price Target on WEREWOLF THERAPEUTICS (HOWL) to USD 6.00 | HOWL Stock News - GuruFocus

May 10, 2025

May 09, 2025

H.C. Wainwright cuts Werewolf Therapeutics target to $10 By Investing.com - Investing.com Nigeria

May 09, 2025

May 09, 2025

H.C. Wainwright cuts Werewolf Therapeutics target to $10 - Investing.com Australia

May 09, 2025

May 09, 2025

Wedbush Adjusts Price Target on Werewolf Therapeutics to $6 From $8, Maintains Outperform Rating - marketscreener.com

May 09, 2025

May 09, 2025

Werewolf Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 09, 2025

May 09, 2025

Werewolf Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025

May 08, 2025

Werewolf Therapeutics (HOWL) Advances Clinical Trials and Expands Educational Initiatives | HOWL Stock News - GuruFocus

May 08, 2025

May 08, 2025

Werewolf Therapeutics Announces Progress in Clinical Trials and Financial Updates for Q1 2025 - Nasdaq

May 08, 2025

May 08, 2025

Renaissance Technologies LLC Decreases Holdings in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

May 08, 2025

May 06, 2025

JPMorgan Chase & Co. Raises Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

May 06, 2025

May 05, 2025

HOWLWerewolf Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

May 05, 2025

May 05, 2025

Werewolf Therapeutics (HOWL) Showcases Innovative IBD Treatment Developments | HOWL Stock News - GuruFocus

May 05, 2025

May 05, 2025

Werewolf Therapeutics reports progress on IBD treatment - Investing.com Australia

May 05, 2025

May 05, 2025

Werewolf Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

May 05, 2025